R. McCormack
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
-
- Lung Cancer Treatments and Mutations 8
- Lung Cancer Diagnosis and Treatment 2
- Gastric Cancer Management and Outcomes 1
-
- Cancer Genomics and Diagnostics 4
- Co-authors
- Tsveta Milenkova (2 shared papers)Manuel Cobo (2 shared papers)Alan Webster (2 shared papers)Gyula Ostoros (2 shared papers)Tudor–Eliade Ciuleanu (1 shared paper)Koichi Hagiwara (4 shared papers)Emma Donald (1 shared paper)Kazuto Nishio (1 shared paper)
- Journals
- Annals of Oncology (3 papers)Genes and Immunity (2 papers)Journal of Clinical Oncology (1 paper)British Journal of Cancer (1 paper)Lung Cancer (1 paper)
- Partner nations
- United KingdomJapanRussia
In The Last Decade
R. McCormack
10 papers receiving 505 citations
R. McCormack's Hit Papers
Peers
Comparison fields: 5 of 39
- Pulmonary and Respiratory Medicine 365
- Cancer Research 160
- Oncology 186
- Pathology and Forensic Medicine 33
- Molecular Biology 99
Countries citing papers authored by R. McCormack
This map shows the geographic impact of R. McCormack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. McCormack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. McCormack more than expected).
Fields of papers citing papers by R. McCormack
This network shows the impact of papers produced by R. McCormack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. McCormack. The network helps show where R. McCormack may publish in the future.
Co-authors
The 25 scholars most cited alongside R. McCormack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study Hit paper breakdown → | 2013 | 331 |
| 2 | 2012 | 93 | |
| 3 | 2015 | 29 | |
| 4 | 2002 | 20 | |
| 5 | 2001 | 18 | |
| 6 | 2015 | 10 | |
| 7 | 2013 | 6 | |
| 8 | 2016 | 5 | |
| 9 | A pharmacological comparison of gefitinib (IRESSA) and erlotinib | 2006 | 2 |
| 10 | 2007 | 1 |
About R. McCormack
R. McCormack is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Genetics and Surgery, having authored 10 papers that have together received 515 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Cancer Genomics and Diagnostics (4 papers), Diabetes and associated disorders (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Diabetes Management and Research (1 paper), Gastric Cancer Management and Outcomes (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (365 citations), Cancer Research (160 citations), Oncology (186 citations), Pathology and Forensic Medicine (33 citations) and Molecular Biology (99 citations). R. McCormack has collaborated with scholars based in United Kingdom, Japan and Russia. Frequent co-authors include Tsveta Milenkova, Manuel Cobo, Alan Webster, Gyula Ostoros, Tudor–Eliade Ciuleanu, Koichi Hagiwara, Emma Donald, Kazuto Nishio, Kōichi Goto and Miyako Satouchi. Their work appears in journals such as Annals of Oncology, Genes and Immunity, Journal of Clinical Oncology, British Journal of Cancer and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.